adult acute myeloid leukemia with 11q23 (MLL) abnormalities
Showing 26 - 50 of >10,000
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)
Recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Houston, Texas
- +5 more
May 31, 2022
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +5 more
-
Portland, Oregon
- +1 more
Jan 15, 2020
AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)
Not yet recruiting
- AML, Adult
- Biological characterization of AML with MECOM or atypical 3q26 rearrangements
- (no location specified)
Apr 21, 2023
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Completed
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- +6 more
- Bosutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 25, 2022
Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Cytarabine
- +4 more
-
Brewer, Maine
- +8 more
Jun 18, 2021
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Active, not recruiting
- Acute Myeloid Leukemia
- +13 more
- Azacitidine
- Gemtuzumab Ozogamicin
-
Burbank, California
- +176 more
Mar 25, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +11 more
- decitabine
- +9 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Nov 13, 2019
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia in Remission
- +8 more
- quality-of-life assessment
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Aug 14, 2019
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute
Recruiting
- Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +9 more
- Cytarabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2021
Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia in Remission
- +16 more
- iodine I 131 monoclonal antibody BC8
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 8, 2019
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal
Recruiting
- Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
- +4 more
- Azacitidine
- +2 more
-
Chicago, IllinoisNorthwestern University
Apr 30, 2021
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- clofarabine
- +7 more
-
Birmingham, Alabama
- +268 more
Feb 23, 2021
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,
Active, not recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +5 more
- Biopsy
- +7 more
-
Lewes, Delaware
- +42 more
Mar 15, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Bone Marrow and Blood Samples in Untreated Acute Myeloid
Completed
- Leukemia
- laboratory biomarker analysis
-
San Diego, California
- +45 more
Aug 2, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +99 more
- alemtuzumab
- +6 more
-
Denver, Colorado
- +6 more
Jan 15, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +99 more
- fludarabine phosphate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 30, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
-
Stanford, CaliforniaStanford University Cancer Institute
Apr 1, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- vorinostat
- +2 more
-
Stanford, California
- +3 more
May 2, 2019